Weiyang He
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Molecular Biology top 10%
- Extracellular vesicles in disease 7
- Genomics, phytochemicals, and oxidative stress 5
- Epigenetics and DNA Methylation 4
- Nephrology top 10%
- Geriatrics and Gerontology top 10%
-
- Liver Disease and Transplantation 5
-
- Bladder and Urothelial Cancer Treatments 7
- Organ Transplantation Techniques and Outcomes 6
-
- Ferroptosis and cancer prognosis 5
- Journals
- SHILAP Revista de lepidopterología (1 paper)The FASEB Journal (2 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiyang He
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 343
- Molecular Biology 715
- Nephrology 70
- Geriatrics and Gerontology 29
- Hepatology 43
Countries citing papers authored by Weiyang He
This map shows the geographic impact of Weiyang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyang He more than expected).
Fields of papers citing papers by Weiyang He
This network shows the impact of papers produced by Weiyang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyang He. The network helps show where Weiyang He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiyang He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 33 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 21 | |
| 6 | 2022 | 17 | |
| 7 | 2021 | 45 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 6 | |
| 11 | 2019 | 126 | |
| 12 | 2019 | 107 | |
| 13 | 2018 | 70 | |
| 14 | 2018 | 17 | |
| 15 | 2018 | 23 | |
| 16 | 2017 | 11 | |
| 17 | 2013 | 43 | |
| 18 | 2012 | 1 | |
| 19 | 2011 | 4 | |
| 20 | [A new method for study of the effect of drugs on cancer cells--31PNMR with perfused cell system]. | 1998 | 1 |
About Weiyang He
Weiyang He is a scholar working on Cancer Research, Hepatology and Toxicology, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (7 papers), Bladder and Urothelial Cancer Treatments (7 papers), Organ Transplantation Techniques and Outcomes (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Ferroptosis and cancer prognosis (5 papers), Liver Disease and Transplantation (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (343 citations), Molecular Biology (715 citations) and Nephrology (70 citations). Weiyang He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xin Gou, Hubin Yin, Gongmin Zhu, Lin Fan, Xinyuan Li, Qifa Ye, Yanfeng Wang, Nian Liu, Lijiao Pei and Xin Gou. Their work appears in journals such as SHILAP Revista de lepidopterología, The FASEB Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.